First Trust Innovation Leaders ETF (NYSEARCA:ILDR – Get Free Report) shares passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $35.97 and traded as low as $35.26. First Trust Innovation Leaders ETF shares last traded at $35.27, with a volume of 64,235 shares changing hands.
First Trust Innovation Leaders ETF Stock Performance
The firm has a fifty day simple moving average of $38.77 and a 200-day simple moving average of $35.97. The firm has a market cap of $326.25 million, a price-to-earnings ratio of 39.35 and a beta of 1.30.
Hedge Funds Weigh In On First Trust Innovation Leaders ETF
Several large investors have recently modified their holdings of the stock. Balance Wealth Partners LLC acquired a new position in First Trust Innovation Leaders ETF in the 3rd quarter valued at about $36,000. Integrated Wealth Concepts LLC bought a new position in First Trust Innovation Leaders ETF in the 2nd quarter valued at about $52,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in First Trust Innovation Leaders ETF in the 3rd quarter valued at about $54,000. Fifth Third Bancorp lifted its position in First Trust Innovation Leaders ETF by 690.2% during the first quarter. Fifth Third Bancorp now owns 5,152 shares of the company’s stock worth $153,000 after acquiring an additional 4,500 shares during the last quarter. Finally, WealthPlan Investment Management LLC acquired a new stake in First Trust Innovation Leaders ETF during the third quarter worth approximately $201,000.
About First Trust Innovation Leaders ETF
The First Trust Innovation Leaders ETF (ILDR) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that seeks capital appreciation by targeting global companies believed to benefit from scientific and technological innovation. ILDR was launched on May 25, 2021 and is managed by First Trust.
Recommended Stories
- Five stocks we like better than First Trust Innovation Leaders ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for First Trust Innovation Leaders ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Innovation Leaders ETF and related companies with MarketBeat.com's FREE daily email newsletter.
